Development Level

Tbio 10,343 | 10,625
Tdark 5,636 | 7,003
Tchem 1,869 | 1,890
Tclin 596 | 602

Collection

Eligible Kinase Proteins 132 | 134
Eligible non-olfactory GPCR Proteins 127 | 143
Eligible Ion Channel Proteins 114 | 117

IMPC Term

preweaning lethality, complete... 630 | 633
preweaning lethality, incomple... 257 | 260
abnormal behavior 222 | 226
decreased lean body mass 194 | 195
embryonic lethality prior to t... 186 | 187
decreased total body fat amoun... 184 | 186
decreased body weight 172 | 174
decreased bone mineral content 157 | 157
embryonic lethality prior to o... 148 | 148
abnormal bone structure 129 | 131
increased or absent threshold ... 127 | 128
decreased bone mineral density 124 | 126
decreased circulating glucose ... 121 | 121
decreased grip strength 120 | 123
increased circulating alkaline... 117 | 119
abnormal embryo size 110 | 112
enlarged heart 109 | 111
decreased body length 107 | 108
increased lean body mass 105 | 107
hyperactivity 104 | 108
abnormal retina morphology 100 | 100
increased bone mineral content 91 | 92
increased mean corpuscular hem... 91 | 93
increased mean corpuscular vol... 91 | 91
hypoactivity 88 | 89
decreased circulating choleste... 84 | 85
decreased circulating triglyce... 83 | 83
increased grip strength 82 | 83
short tibia 81 | 82
decreased circulating serum al... 78 | 79
decreased circulating HDL chol... 76 | 77
decreased circulating insulin ... 73 | 75
abnormal lens morphology 72 | 73
increased circulating sodium l... 70 | 71
increased fasted circulating g... 68 | 68
increased circulating HDL chol... 62 | 63
prenatal lethality prior to he... 62 | 64
abnormal sleep behavior 61 | 63
decreased lumbar vertebrae num... 61 | 62
increased sacral vertebrae num... 61 | 62
male infertility 61 | 62
abnormal retinal pigmentation 60 | 61
decreased rib number 59 | 59
increased total body fat amoun... 57 | 57
increased exploration in new e... 56 | 56
improved glucose tolerance 55 | 56
abnormal coat/hair pigmentatio... 54 | 54
decreased leukocyte cell numbe... 54 | 54
abnormal bone mineralization 52 | 55
decreased hemoglobin content 52 | 53
increased bone mineral density 52 | 52
increased circulating choleste... 52 | 53
abnormal behavioral response t... 51 | 52
abnormal gait 51 | 51
abnormal heart morphology 51 | 51
decreased circulating alanine ... 51 | 53
decreased prepulse inhibition 51 | 52
impaired glucose tolerance 51 | 52
decreased mean corpuscular vol... 50 | 50
decreased caudal vertebrae num... 48 | 49
decreased fasted circulating g... 48 | 49
decreased startle reflex 48 | 48
abnormal seminal vesicle morph... 46 | 47
increased hemoglobin content 45 | 45
thrombocytopenia 45 | 46
decreased heart weight 44 | 44
increased blood urea nitrogen ... 43 | 44
increased circulating chloride... 43 | 43
decreased erythrocyte cell num... 42 | 43
increased body weight 42 | 42
decreased eosinophil cell numb... 41 | 41
decreased circulating total pr... 40 | 41
increased rib number 40 | 41
decreased circulating alkaline... 39 | 41
decreased circulating free fat... 39 | 39
increased startle reflex 38 | 38
abnormal eye morphology 37 | 38
abnormal neural tube closure 37 | 37
decreased circulating LDL chol... 37 | 37
decreased neutrophil cell numb... 36 | 37
increased hematocrit 36 | 36
increased leukocyte cell numbe... 36 | 37
small testis 36 | 37
abnormal spleen morphology 35 | 36
cardiovascular system phenotyp... 35 | 35
increased heart weight 35 | 37
limb grasping 34 | 35
decreased circulating calcium ... 33 | 33
decreased mean corpuscular hem... 33 | 34
female infertility 33 | 34
abnormal cranium morphology 32 | 32
decreased circulating chloride... 32 | 32
increased circulating calcium ... 32 | 32
tremors 32 | 34
decreased circulating creatini... 31 | 31
decreased circulating fructosa... 31 | 31
decreased threshold for audito... 31 | 32
increased circulating potassiu... 31 | 31
abnormal epididymis morphology 30 | 31
decreased T cell number 30 | 31

Disease

ovarian cancer 8,378 | 8,484
osteosarcoma 7,778 | 7,933
psoriasis 6,465 | 6,685
medulloblastoma, large-cell 6,151 | 6,234
glioblastoma 5,508 | 5,572
lung cancer 4,418 | 4,466
atypical teratoid / rhabdoid tumor 4,317 | 4,369
intraductal papillary-mucinous neoplasm (IPMN) 3,248 | 3,289
malignant mesothelioma 3,129 | 3,162
Breast cancer 3,062 | 3,094
pilocytic astrocytoma 3,052 | 3,086
primitive neuroectodermal tumor 3,001 | 3,031
intraductal papillary-mucinous carcinoma (IPMC) 2,953 | 2,988
invasive ductal carcinoma 2,926 | 2,950
intraductal papillary-mucinous adenoma (IPMA) 2,925 | 2,956
oligodendroglioma 2,822 | 2,849
lung carcinoma 2,797 | 2,844
non-small cell lung cancer 2,775 | 2,798
pediatric high grade glioma 2,679 | 2,712
lung adenocarcinoma 2,678 | 2,713
ependymoma 2,493 | 2,514
pancreatic cancer 2,280 | 2,300
interstitial cystitis 2,273 | 2,299
subependymal giant cell astrocytoma 2,257 | 2,287
group 3 medulloblastoma 2,226 | 2,254
Cancer 2,219 | 2,346
astrocytic glioma 2,215 | 2,241
adult high grade glioma 2,114 | 2,148
Carcinoma 2,113 | 2,147
ulcerative colitis 2,066 | 2,087
pituitary cancer 1,954 | 1,972
Pick disease 1,881 | 1,893
group 4 medulloblastoma 1,853 | 1,875
pancreatic ductal adenocarcinoma liver metastasis 1,781 | 1,795
ductal carcinoma in situ 1,731 | 1,745
cystic fibrosis 1,650 | 1,665
breast carcinoma 1,600 | 1,614
tuberculosis 1,540 | 1,557
diabetes mellitus 1,515 | 1,663
posterior fossa group B ependymoma 1,509 | 1,530
medulloblastoma 1,507 | 1,524
posterior fossa group A ependymoma 1,491 | 1,511
astrocytoma 1,481 | 1,493
sonic hedgehog group medulloblastoma 1,465 | 1,482
colon cancer 1,459 | 1,475
adrenocortical carcinoma 1,416 | 1,427
Multiple myeloma 1,322 | 1,327
primary pancreatic ductal adenocarcinoma 1,270 | 1,271
juvenile dermatomyositis 1,183 | 1,189
acute quadriplegic myopathy 1,150 | 1,157
Rheumatoid Arthritis 1,116 | 1,160
atypical teratoid/rhabdoid tumor 1,081 | 1,095
spina bifida 1,057 | 1,064
cutaneous lupus erythematosus 1,045 | 1,056
nasopharyngeal carcinoma 1,045 | 1,056
Atopic dermatitis 930 | 944
dermatomyositis 928 | 933
active Crohn's disease 907 | 918
gastric carcinoma 822 | 832
non primary Sjogren syndrome sicca 819 | 840
primary Sjogren syndrome 779 | 789
acute myeloid leukemia 776 | 780
Waldenstrons macroglobulinemia 764 | 765
esophageal adenocarcinoma 733 | 737
tuberculosis and treatment for 6 months 680 | 686
progressive supranuclear palsy 667 | 674
aldosterone-producing adenoma 662 | 664
Alzheimer's disease 632 | 644
Obesity 603 | 616
Duchenne muscular dystrophy 596 | 602
Intellectual disability 566 | 573
pancreatic carcinoma 564 | 567
fibroadenoma 553 | 557
Down syndrome 540 | 548
Endometriosis 528 | 535
hepatocellular carcinoma 525 | 532
chronic rhinosinusitis 507 | 512
autosomal dominant Emery-Dreifuss muscular dystrophy 498 | 499
Schizophrenia 491 | 501
mucosa-associated lymphoid tissue lymphoma 473 | 480
active ulcerative colitis 469 | 477
Multiple Sclerosis 466 | 498
Prostatic Neoplasms 466 | 471
IGA Glomerulonephritis 450 | 454
Amyotrophic Lateral Sclerosis 429 | 431
gastric cancer 423 | 430
non-small cell lung carcinoma 407 | 413
Mammary Neoplasms 406 | 410
inflammatory breast cancer 394 | 404
Neurodegenerative disease 378 | 383
Kidney disease 372 | 396
Parkinson's disease 359 | 364
sarcoidosis 352 | 358
glioblastoma multiforme 343 | 347
Asthma 341 | 349
Epilepsy 340 | 346
nephrosclerosis 329 | 329
Polycystic Ovary Syndrome 324 | 332
tuberculosis and treatment for 3 months 324 | 327
urothelial carcinoma 314 | 318

Tissue

Urinary Tract 18,444 | 18,444
Female tissues 18,647 | 18,647
Nervous System 18,561 | 18,561
Endocrine System 18,512 | 18,512
Digestive Tract 18,473 | 18,473
Liver and Pancreas 18,136 | 18,136
Skin and soft tissues 18,115 | 18,115
Blood and immune system 17,995 | 17,995
Male tissues 17,969 | 17,969
Cardiovascular System 17,958 | 17,958
Respiratory system 17,484 | 17,484

Target Family

Non-IDG 10,645 | 11,971
Enzyme 4,007 | 4,146
Transcription Factor 1,369 | 1,400
Kinase 627 | 634
Transporter 462 | 473
GPCR 382 | 406
Ion Channel 336 | 341
oGPCR 294 | 421
Epigenetic 237 | 242
Nuclear Receptor 47 | 48
TF/Epigenetic 38 | 38

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Mitochondrial 2-oxodicarboxylate carrier SLC25A21 Tbio Transporter -0.46900 2.68 102
Zinc finger and BTB domain-containing protein 1 ZBTB1 Tbio Transcription Factor -0.57513 5.01 57
HLA class I histocompatibility antigen, A-3 alpha chain HLA-A Tbio Non-IDG -3.60614 4042.7 585
GTPase KRas KRAS Tbio Enzyme -3.75582 5694.2 421
RNA pseudouridylate synthase domain-containing protein 3 RPUSD3 Tdark Enzyme 0.42 34
D(2) dopamine receptor DRD2 Tclin GPCR -3.24474 1775.2 248
Dehydrogenase/reductase SDR family member 12 DHRS12 Tdark Enzyme 0.11 0.56 23
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
F-box only protein 47 FBXO47 Tdark Non-IDG 0.08 0.95 47
Zinc finger protein 136 ZNF136 Tdark Transcription Factor 0.12 0.68 102